Strs Ohio Increases Stake in Halozyme Therapeutics, Inc. $HALO
MarketBeat
Strs Ohio raised its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 899.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 27,775 shares of the biopharmaceutical company's stock after purchasing an additional 24,996 shares during the qua
NASDAQ:HALO